Alterity Therapeutics (ATHE) Retained Earnings (2017 - 2018)
Alterity Therapeutics (ATHE) has 2 years of Retained Earnings data on record, last reported at -$98.1 million in Q2 2018.
- For Q2 2018, Retained Earnings fell 6.47% year-over-year to -$98.1 million; the TTM value through Jun 2018 reached -$98.1 million, down 6.47%, while the annual FY2018 figure was -$98.1 million, 6.07% down from the prior year.
- Retained Earnings reached -$98.1 million in Q2 2018 per ATHE's latest filing, down from -$92.1 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$92.1 million in Q2 2017 and bottomed at -$98.1 million in Q2 2018.